2021, Volume 1, Number 1
Lishnevska V. Hepatoprotective Therapy for Disease and Diabetes
Our work is devoted to the treatment of non-alcoholic fatty liver disease as a complication in patients with complex cardiovascular pathology and type 2 dia- betes mellitus. The data of the study of the effect of the drug Hepa-Merz® on the functional state of the liver, endothelium, rheological properties of blood, the state of capillary blood fl ow, markers of endotoxicosis and clinical state in this category of patients are presented. The obtained results confi rm the pos- sibility vlience drug Hepa-Merz® on the functional disorders of the liver in patients with cardiovascular disease and complex type 2 diabetes.ავტორი: Lishnevska V.